摘要

Lymphocytic pleurisy is commonly observed in tuberculosis and cancer. Noninvasive biomarkers are needed to distinguish tuberculous pleural effusion (TPE) from malignant pleural effusion (MPE) because current clinical diagnostic procedures are often invasive. We identified immune response biomarkers that can discriminate between TPE and MPE. Fourteen pleural effusion biomarkers were compared in 22 MPE patients and five TPE patients. Of the innate immunity biomarkers, the median levels of interleukin (IL)-1βand interferon-induced protein-10 (IP-10) were higher in TPE patients than in MPE patients (P
原文英語
頁(從 - 到)183-189
頁數7
期刊International Journal of General Medicine
9
DOIs
出版狀態已發佈 - 六月 11 2016

ASJC Scopus subject areas

  • Medicine(all)

指紋 深入研究「Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion」主題。共同形成了獨特的指紋。

  • 引用此